Drug profile · INN
tepotinib hydrochloride
TEPMETKO
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tepotinib hydrochloride (TEPMETKO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tepotinib hydrochloride
Brand TEPMETKO
Route ORAL
Formulation TABLET
Frequently asked questions
What is tepotinib hydrochloride?
tepotinib hydrochloride (TEPMETKO) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tepotinib hydrochloride?
TEPMETKO is a marketed brand name for tepotinib hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tepotinib hydrochloride?
tepotinib hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.